Latest Breaking News On - Nareg sagherian - Page 4 : comparemela.com

Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Jefferies Healthcare Conference June 7-8, 2023

Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Jefferies Healthcare Conference June 7-8, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Marriott marquisIntercept pharmaceuticals incCompany on twitterJefferies healthcare conferenceNew york cityDetails forNareg sagherianIntercept pharmaceuticals

Intercept Pharma (ICPT) Announces Vote Not Favoring Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH

Intercept Pharma (ICPT) Announces Vote Not Favoring Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Karen prebleJerry dursoNareg sagherianGastrointestinal drugs advisory committeeCompany on twitterIntercept pharmaceuticals incAdvisory committeeCompany new drug applicationDrug administrationGlobal corporate communicationsAdvisory committee meetingEtthe companyWall streetNew drug applicationChief executive officerPrescription drug user fee act

Intercept Pharmaceuticals, Inc : Intercept Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH

MORRISTOWN, N.J., May 19, 2023 (GLOBE NEWSWIRE) Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to

Karen prebleGewinn nurNareg sagherianGlobal corporate communicationsAdvisory committeeGastrointestinal drugs advisory committeeDrug administrationIntercept pharmaceuticals incPrescription drug user fee actExecutive directorGlobal investor relations

Intercept Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH

MORRISTOWN, N.J., May 19, 2023 Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral. | May 19, 2023

Karen prebleNareg sagherianAdvisory committeeGlobenewswire incGastrointestinal drugs advisory committeeIntercept pharmaceuticals incDrug administrationCompany on twitterGlobal corporate communicationsDrugs advisory committeePrescription drug user fee actExecutive directorGlobal investor relationsIntercept pharmaceuticalsNc stock exchangePress release

Intercept Announces Outcome of FDA Advisory Committee Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH

Intercept Announces Outcome of FDA Advisory Committee Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Karen prebleJerry dursoNareg sagherianIntercept pharmaceuticals incEtthe companyGastrointestinal drugs advisory committeeDrug administrationAdvisory committeeAdvisory committee meetingCompany new drug applicationGlobal corporate communicationsCompany on twitterAction dateNew drug applicationChief executive officerPrescription drug user fee act